Urgent Care Clinical Trials

Urgent Care Clinical Trials is a clinical research Site Management Organization (SMO) developing the first national Investigative Site Network (ISN) specifically geared to the urgent care industry. However, Urgent Care Clinical Trials does not limit themselves to only urgent care centers. As the urgent care industry continues to grow and align with complementary healthcare, so do we. We operate with pain management facilities, primary care groups, cardiologists, dermatologists, and more.

Unima

Unima develops fast and low cost diagnostic and disease surveillance technologies to solve the problem of lack of access to a timely diagnostic for 3 billion people living in the developing world or in low resource settings in high income countries.

CONTEX Groupe

Fondée en 2015, la société CONTEX s'est rapidement imposée comme un acteur incontournable dans le secteur du diagnostic et de la maîtrise d'ouvrage. Spécialisée dans les diagnostics avant travaux et la gestion de projets, l'entreprise a su répondre aux besoins croissants de ses clients en proposant des services de qualité et en s'adaptant aux évolutions du marché pour proposer une offre globale spécialisée dans la réhabilitation. Avec un chiffre d'affaires 2022 de 3,2 millions d'euros, CONTEX présente une croissance soutenue et une solide réputation auprès de sa clientèle. La société s'appuie sur une équipe de professionnels qualifiés et expérimentés pour fournir des prestations adaptées à chaque projet. Les prestations proposées par CONTEX sont variées et répondent aux exigences réglementaires et techniques des projets de construction et de rénovation. Parmi ces services, on retrouve notamment : 1. Diagnostics avant travaux : CONTEX réalise des diagnostics avant la réalisation de travaux, afin de détecter la présence de matériaux dangereux tels que l'amiante ou le plomb. 2. Diagnostics structure : La société évalue la solidité et la stabilité des structures existantes et réalise les investigations indispensables à une connaissance structurelle du bâti en vue de la réalisation de travaux de rénovation ou de transformation. Cette expertise est essentielle pour assurer la sécurité des occupants, les études préalables à tout projet et la pérennité des ouvrages. 3. Assistance à Maîtrise d'Ouvrage (AMO) : CONTEX accompagne ses clients tout au long de leur projets, de la phase d'audit avant acquisition et définition du projet à la réception des travaux. Cette prestation inclut la planification, le suivi et le contrôle des travaux, ainsi que la coordination des différents intervenants avec une expertise particulière aux projets de réhabilitation.

C-PlaNeT

C-PlaNeT is a consortium of high-profile universities, research institutions and companies located in Belgium, Germany, the Netherlands, Austria, United Kingdom, Switzerland, Denmark and Greece. ​ Europe needs this training network. Bringing plastics into the circular economy is one of the great challenges of our age. C-PlaNeT lays the foundations for a New Plastics Economy through a European Joint Doctoral Programme that trains 15 Early Stage Researchers (ESRs) to become part of a new generation of scientists, engineers and policy makers for the EU's circular economy, which must include the design, processing, use and reuse of plastics. Each ESR, developing his/her research skills together with a supervisor and co-promoter, represents a piece of the jigsaw, at the same time benefiting from being part of a project team with 14 other ESRs and their supervisors covering other parts of the life cycle, challenging each other in terms of lifecycle thinking and a much more sustainable future for plastics.

CXR Biosciences: the investigative and exploratory toxicology company (now Concept Life Sciences)

CXR Biosciences is now Concept Life Sciences. To keep up to date with our news at Concept Life Sciences, please follow Concept Life Sciences Integrated Discovery & Development Division page: https://www.linkedin.com/company/11052107 CXR Biosciences provides preclinical services and expertise, specialising in investigative toxicology, exploratory and discovery toxicology, metabolism and pharmacokinetics: - Investigative & Mechanistic Toxicology: by understanding the pathways that define the sensitivity of organs and cells to chemicals, we explain observed toxicities and evaluate the actual hazard and/or risk to humans. We have extensive experience in evaluating toxicological processes across species, and determining the relevance to humans of observed adverse reactions to the satisfaction of regulatory bodies. - Exploratory & Discovery Toxicology: R&D failure due to unexpected toxicity is a leading cause of attrition in the agrochemical, chemical and pharmaceutical industries. In order to improve productivity, identification of potential toxic hazard and quantification of potential risk is shifting from the development stage to the research stage of R&D. We use mechanistic toxicology at the research stage to drive chemical design, candidate selection and translational risk assessment. - Metabolism & PK/TK Support: a full understanding of the metabolism of compounds is required in the biological systems to which the product will be exposed (for example aos mandated by Regulation EC 1107/2009 for agrochemicals). CXR Biosciences routinely works with agrochemical, chemical and pharmaceutical companies to generate metabolic profiling data for new products, data gap fill and update to new regulations to supprt resubmissions.